{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:24:25Z","timestamp":1784204665678,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Chang-Gung Medical Research Progress","award":["Grant CMRPG 3G0441 and CMRPG3K0261"],"award-info":[{"award-number":["Grant CMRPG 3G0441 and CMRPG3K0261"]}]},{"name":"the National Science Council","award":["Grants NSC 102-2314-B-182A-039-MY3, MOST 106-2314-B-182A-147, MOST 109-2314-B-182A-109, NMRPG3G0381 and PMRPG3H0051"],"award-info":[{"award-number":["Grants NSC 102-2314-B-182A-039-MY3, MOST 106-2314-B-182A-147, MOST 109-2314-B-182A-109, NMRPG3G0381 and PMRPG3H0051"]}]},{"DOI":"10.13039\/501100020433","name":"Taiwan Foundation for Rare Disorders","doi-asserted-by":"crossref","award":["TFRD"],"award-info":[{"award-number":["TFRD"]}],"id":[{"id":"10.13039\/501100020433","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10875-021-01055-x","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T08:05:33Z","timestamp":1620461133000},"page":"1303-1314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical Features of Female Taiwanese Carriers with X-linked Chronic Granulomatous Disease from 2004 to 2019"],"prefix":"10.1007","volume":"41","author":[{"given":"Chao-Yi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2683-3169","authenticated-orcid":false,"given":"Wen-I","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Long","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Shiou","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Chieh","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang-Her","family":"Jaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hsiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Jou","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chen","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsun","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,8]]},"reference":[{"issue":"3","key":"1055_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00005792-200005000-00004","volume":"79","author":"BH Segal","year":"2000","unstructured":"Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79(3):170\u2013200. https:\/\/doi.org\/10.1097\/00005792-200005000-00004.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1055_CR2","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jaci.2018.09.019","volume":"143","author":"DC Thomas","year":"2019","unstructured":"Thomas DC, Charbonnier LM, Schejtman A, et al. EROS\/CYBC1 mutations: decreased NADPH oxidase function and chronic granulomatous disease. J Allergy Clin Immunol. 2019;143(2):782-785.e1. https:\/\/doi.org\/10.1016\/j.jaci.2018.09.019.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1055_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/MOP.0000000000000830","volume":"31","author":"R Lacerda-Pontes","year":"2019","unstructured":"Lacerda-Pontes R, Gomes LN, Albuquerque RS, Soeiro-Pereira PV, Condino-Neto A. The extended understanding of chronic granulomatous disease. Curr Opin Pediatr. 2019;31(6):869\u201373. https:\/\/doi.org\/10.1097\/MOP.0000000000000830.","journal-title":"Curr Opin Pediatr"},{"issue":"4","key":"1055_CR4","first-page":"291","volume":"70","author":"M Cazzola","year":"1985","unstructured":"Cazzola M, Sacchi F, Pagani A, et al. X-linked chronic granulomatous disease in an adult woman. Evidence for a cell selection favoring neutrophils expressing the mutant allele. Haematologica. 1985;70(4):291\u20135.","journal-title":"Haematologica."},{"issue":"2","key":"1055_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1067\/mai.2003.58","volume":"111","author":"O Jirapongsananuruk","year":"2003","unstructured":"Jirapongsananuruk O, Malech HL, Kuhns DB, et al. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay. J Allergy Clin Immunol. 2003;111(2):374\u20139. https:\/\/doi.org\/10.1067\/mai.2003.58.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1055_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10875-019-00725-1","volume":"40","author":"F Pulvirenti","year":"2020","unstructured":"Pulvirenti F, Sangerardi M, Plebani A, et al. Health-related quality of life and emotional difficulties in chronic granulomatous disease: data on adult and pediatric patients from Italian Network for Primary Immunodeficiency (IPINet). J Clin Immunol. 2020;40(2):289\u201398. https:\/\/doi.org\/10.1007\/s10875-019-00725-1.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1055_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","volume":"26","author":"DB Kohn","year":"2020","unstructured":"Kohn DB, Booth C, Kang EM, et al. Lentiviral gene therapy for X-linked chronic granulomatous disease. Nat Med. 2020;26(2):200\u20136. https:\/\/doi.org\/10.1038\/s41591-019-0735-5.","journal-title":"Nat Med"},{"issue":"1","key":"1055_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/clinchem\/44.1.61","volume":"44","author":"N El Kassar","year":"1998","unstructured":"El Kassar N, Hetet G, Bri\u00e8re J, Grandchamp B. X-chromosome inactivation in healthy females: incidence of excessive lyonization with age and comparison of assays involving DNA methylation and transcript polymorphisms. Clin Chem. 1998;44(1):61\u20137.","journal-title":"Clin Chem"},{"issue":"4","key":"1055_CR9","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1172\/JCI112140","volume":"76","author":"ES Buescher","year":"1985","unstructured":"Buescher ES, Alling DW, Gallin JI. Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool. J Clin Invest. 1985;76(4):1581\u20134. https:\/\/doi.org\/10.1172\/JCI112140.","journal-title":"J Clin Invest"},{"issue":"8795","key":"1055_CR10","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0140-6736(92)90653-k","volume":"339","author":"JT Curnutte","year":"1992","unstructured":"Curnutte JT, Hopkins PJ, Kuhl W, Beutler E. Studying X inactivation. Lancet. 1992;339(8795):749. https:\/\/doi.org\/10.1016\/0140-6736(92)90653-k.","journal-title":"Lancet"},{"issue":"1","key":"1055_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/ecco-jcc\/jjv186","volume":"10","author":"F Hauck","year":"2016","unstructured":"Hauck F, Koletzko S, Walz C, et al. Diagnostic and treatment options for severe IBD in female X-CGD carriers with non-random X-inactivation. J Crohns Colitis. 2016;10(1):112\u20135. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv186.","journal-title":"J Crohns Colitis"},{"issue":"2","key":"1055_CR12","first-page":"149","volume":"3","author":"JT Curnutte","year":"1992","unstructured":"Curnutte JT. Molecular basis of the autosomal recessive forms of chronic granulomatous disease. Immunodefic Rev. 1992;3(2):149\u201372.","journal-title":"Immunodefic Rev"},{"issue":"4","key":"1055_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood.V77.4.673.673","volume":"77","author":"RM Smith","year":"1991","unstructured":"Smith RM, Curnutte JT. Molecular basis of chronic granulomatous disease. Blood. 1991;77(4):673\u201386.","journal-title":"Blood"},{"issue":"5","key":"1055_CR14","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1182\/blood.V87.5.1663.1663","volume":"87","author":"D Roos","year":"1996","unstructured":"Roos D, de Boer M, Kuribayashi F, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood. 1996;87(5):1663\u201381.","journal-title":"Blood"},{"issue":"3","key":"1055_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","volume":"79","author":"JA Winkelstein","year":"2000","unstructured":"Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79(3):155\u201369. https:\/\/doi.org\/10.1097\/00005792-200005000-00003.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1055_CR16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s12041-015-0574-1","volume":"94","author":"CM Disteche","year":"2015","unstructured":"Disteche CM, Berletch JB. X-chromosome inactivation and escape. J Genet. 2015;94(4):591\u20139. https:\/\/doi.org\/10.1007\/s12041-015-0574-1.","journal-title":"J Genet"},{"issue":"5","key":"1055_CR17","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1182\/blood-2003-12-4420","volume":"105","author":"WI Lee","year":"2005","unstructured":"Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005;105(5):1881\u201390. https:\/\/doi.org\/10.1182\/blood-2003-12-4420.","journal-title":"Blood"},{"issue":"2","key":"1055_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0022-1759(96)00024-5","volume":"191","author":"LJ van Pelt","year":"1996","unstructured":"van Pelt LJ, van Zwieten R, Weening RS, Roos D, Verhoeven AJ, Bolscher BG. Limitations on the use of dihydrorhodamine 123 for flow cytometric analysis of the neutrophil respiratory burst. J Immunol Methods. 1996;191(2):187\u201396. https:\/\/doi.org\/10.1016\/0022-1759(96)00024-5.","journal-title":"J Immunol Methods"},{"issue":"12","key":"1055_CR19","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.4049\/jimmunol.170.12.6082","volume":"170","author":"JB Burritt","year":"2003","unstructured":"Burritt JB, Foubert TR, Baniulis D, et al. Functional epitope on human neutrophil flavocytochrome b558. J Immunol. 2003;170(12):6082\u20139. https:\/\/doi.org\/10.4049\/jimmunol.170.12.6082.","journal-title":"J Immunol"},{"issue":"3","key":"1055_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s10875-006-9013-7","volume":"26","author":"WI Lee","year":"2006","unstructured":"Lee WI, Jaing TH, Hsieh MY, Kuo ML, Lin SJ, Huang JL. Distribution, infections, treatments and molecular analysis in a large cohort of patients with primary immunodeficiency diseases (PIDs) in Taiwan. J Clin Immunol. 2006;26(3):274\u201383. https:\/\/doi.org\/10.1007\/s10875-006-9013-7.","journal-title":"J Clin Immunol"},{"issue":"5","key":"1055_CR21","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/s0015-0282(01)02845-x","volume":"76","author":"S Uehara","year":"2001","unstructured":"Uehara S, Hashiyada M, Sato K, Sato Y, Fujimori K, Okamura K. Preferential X-chromosome inactivation in women with idiopathic recurrent pregnancy loss. Fertil Steril. 2001;76(5):908\u201314. https:\/\/doi.org\/10.1016\/s0015-0282(01)02845-x.","journal-title":"Fertil Steril"},{"key":"1055_CR22","unstructured":"Global variome shared LOVD CYBB (cytochrome b-245, beta polypeptide) https:\/\/databases.lovd.nl\/shared\/variants\/CYBB."},{"issue":"3","key":"1055_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bcmd.2010.07.012","volume":"45","author":"D Roos","year":"2010","unstructured":"Roos D, Kuhns DB, Maddalena A, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45(3):246\u201365. https:\/\/doi.org\/10.1016\/j.bcmd.2010.07.012.","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"1055_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jaci.2017.04.035","volume":"141","author":"BE Marciano","year":"2018","unstructured":"Marciano BE, Zerbe CS, Falcone EL, et al. X-linked carriers of chronic granulomatous disease: illness, lyonization, and stability. J Allergy Clin Immunol. 2018;141(1):365\u201371. https:\/\/doi.org\/10.1016\/j.jaci.2017.04.035.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1055_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.18176\/jiaci.0343","volume":"29","author":"I L\u00f3pez-Hern\u00e1ndez","year":"2019","unstructured":"L\u00f3pez-Hern\u00e1ndez I, Guzm\u00e1n-Mart\u00ednez MN, Medina-Vera I, et al. Clinical manifestations in carriers of X-linked chronic granulomatous disease in Mexico. J Investig Allergol Clin Immunol. 2019;29(2):134\u20136. https:\/\/doi.org\/10.18176\/jiaci.0343.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"2","key":"1055_CR26","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jaci.2017.02.029","volume":"140","author":"AC Battersby","year":"2017","unstructured":"Battersby AC, Braggins H, Pearce MS, et al. Inflammatory and autoimmune manifestations in X-linked carriers of chronic granulomatous disease in the United Kingdom. J Allergy Clin Immunol. 2017;140(2):628-630.e6. https:\/\/doi.org\/10.1016\/j.jaci.2017.02.029.","journal-title":"J Allergy Clin Immunol"},{"key":"1055_CR27","doi-asserted-by":"crossref","unstructured":"van den Berg JM, van Koppen E, \u00c5hlin A, et al. Chronic granulomatous disease: the European experience. PLoS ONE. 2009;4(4).","DOI":"10.1371\/journal.pone.0005234"},{"issue":"5","key":"1055_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1046\/j.1442-200x.1999.01129.x","volume":"41","author":"TS Hasui","year":"1999","unstructured":"Hasui TS. Chronic granulomatous disease in Japan: incidence and natural history. The Study Group of Phagocyte Disorders of Japan. Pediatr Int. 1999;41(5):589\u201393.","journal-title":"Pediatr Int"},{"issue":"6","key":"1055_CR29","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/s0022-3476(99)70299-4","volume":"134","author":"D Goldblatt","year":"1999","unstructured":"Goldblatt D, Butcher J, Thrasher AJ, Russell-Eggitt I. Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr. 1999;134(6):780\u20133. https:\/\/doi.org\/10.1016\/s0022-3476(99)70299-4.","journal-title":"J Pediatr"},{"issue":"2","key":"1055_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s002770000230","volume":"80","author":"A R\u00f6sen-Wolff","year":"2001","unstructured":"R\u00f6sen-Wolff A, Soldan W, Heyne K, Bickhardt J, Gahr M, Roesler J. Increased susceptibility of a carrier of X-linked chronic granulomatous disease (CGD) to Aspergillus fumigatus infection associated with age-related skewing of lyonization. Ann Hematol. 2001;80(2):113\u20135. https:\/\/doi.org\/10.1007\/s002770000230.","journal-title":"Ann Hematol"},{"issue":"5","key":"1055_CR31","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/clinchem\/48.5.780","volume":"48","author":"A Lun","year":"2002","unstructured":"Lun A, Roesler J, Renz H. Unusual late onset of X-linked chronic granulomatous disease in an adult woman after unsuspicious childhood. Clin Chem. 2002;48(5):780\u20131.","journal-title":"Clin Chem"},{"issue":"3","key":"1055_CR32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.clim.2003.08.002","volume":"109","author":"M Anderson-Cohen","year":"2003","unstructured":"Anderson-Cohen M, Holland SM, Kuhns DB, et al. Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non familial, extremely skewed X chromosome inactivation. Clin Immunol. 2003;109(3):308\u201317. https:\/\/doi.org\/10.1016\/j.clim.2003.08.002.","journal-title":"Clin Immunol"},{"issue":"2","key":"1055_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00431-006-0211-3","volume":"166","author":"S Chollet-Martin","year":"2007","unstructured":"Chollet-Martin S, Lopez A, Gaud C, et al. Severe X-linked chronic granulomatous disease in two unrelated females. Eur J Pediatr. 2007;166(2):153\u20139. https:\/\/doi.org\/10.1007\/s00431-006-0211-3.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"1055_CR34","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jaci.2016.01.033","volume":"137","author":"M Migliavacca","year":"2016","unstructured":"Migliavacca M, Assanelli A, Ferrua F, et al. Pioglitazone as a novel therapeutic approach in chronic granulomatous disease. J Allergy Clin Immunol. 2016;137(6):1913-1915.e2. https:\/\/doi.org\/10.1016\/j.jaci.2016.01.033.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1055_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10875-019-00719-z","volume":"40","author":"X Hui","year":"2020","unstructured":"Hui X, Liu D, Wang W, et al. Low-dose pioglitazone does not increase ROS production in chronic granulomatous disease patients with severe infection. J Clin Immunol. 2020;40(1):131\u20137. https:\/\/doi.org\/10.1007\/s10875-019-00719-z.","journal-title":"J Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01055-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-021-01055-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01055-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T02:07:18Z","timestamp":1627265238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-021-01055-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,8]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1055"],"URL":"https:\/\/doi.org\/10.1007\/s10875-021-01055-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,8]]},"assertion":[{"value":"30 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}